Drug Profile
Research programme: antimalarials - Collaborative Drug Discovery/St Jude Children's Research Hospital
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Collaborative Drug Discovery; St. Jude Childrens Research Hospital
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malaria in USA
- 11 Oct 2007 Preclinical trials in Malaria in USA (unspecified route)